New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial - The New York Times

kept by eddie dec 12, 25

A clinical trial of Eli Lilly's retatrutide, which targets three hormones, resulted in significantly greater weight loss than any currently approved drug.

Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value - The New York Times
Eli Lilly, the drugmaker behind Zepbound and Mounjaro, became the first health-care company to achieve a $1 trillion market value.
also on Zepbound, Eli Lilly, #healthcare
Not For Human Consumption - by Somewhere - Vectorculture
Grey market peptides have built a parallel pharmaceutical infrastructure under the thinnest regulatory pretense, revealing a cultural contradiction beyond weight loss.
also on #weight-loss, Eli Lilly
How AI is supercharging drug development
AI is accelerating drug development, with a proprietary survey showing it is driving broader automation that is reshaping early-stage pharmaceutical research across the industry.
also on #drug-development, #healthcare
The golden age of vaccine development - Works in Progress Magazine
Vaccine development has progressed from serendipitous discoveries to a systematic, atomic-precision science, enabling the design of new vaccines in weeks rather than centuries.
also on #healthcare, #research
Anti-aging injection regrows knee cartilage and prevents arthritis
Blocking the 15-PGDH protein via injection regrows knee cartilage and prevents arthritis in aging and injured mice, with potential for human therapy.
also on #healthcare, #research